Epithelial control of responses to allergen challenge and viral exacerbation

上皮细胞对过敏原挑战和病毒恶化反应的控制

基本信息

项目摘要

Project Summary It is well known that infection by respiratory viruses (e.g., RSV or RV) can exacerbate responses in individuals who are allergic asthmatics. It is our hypothesis that the airway epithelium is the central coordinator of responses to respiratory virus infection, as well as to allergens. Intrinsic differences in airway epithelial cells (AEC) in healthy and asthmatic individuals play an important role in this exacerbated response. AECs from asthmatics respond in a different manner to infection than AECs from healthy subjects. These differences are manifested during infection in several ways, including changes in the expression and deposition of extra cellular matrix components and qualitative and quantitative differences in the expression of cytokines and chemokines. This altered response in asthmatic AEC leads to changes in both innate and adaptive responses during infection, with increased infiltration of the airways with leukocytes. The primary goal of this Program is to identify and characterize these changes in asthmatic AECs, and determine their effects on the innate and adaptive immune response. With this goal in mind, we will (1) Determine the role of the epithelium in regulating ECM and leukocyte adhesion in viral-triggered asthma; (2) Determine the regulation of the Innate Immune response by the epithelium in asthma; (3) Determine the role of the epithelium in regulating T cell responses in asthma.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven F Ziegler其他文献

The role of Bcl11b in lineage commitment of CD4+CD8+DP thymocytes via regulation of ThPOK silencer activity
Bcl11b 通过调节 ThPOK 沉默子活性在 CD4 CD8 DP 胸腺细胞谱系定型中的作用
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Miyuki Omori-Miyake;Steven F Ziegler;田中宏和
  • 通讯作者:
    田中宏和
Thymic stromal lymphopoietin in normal and pathogenic T cell development and function
胸腺基质淋巴细胞生成素在正常和致病性 T 细胞发育与功能中的作用
  • DOI:
    10.1038/ni1360
  • 发表时间:
    2006-06-19
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Steven F Ziegler;Yong-Jun Liu
  • 通讯作者:
    Yong-Jun Liu

Steven F Ziegler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven F Ziegler', 18)}}的其他基金

Foxp3 isoforms and IgE-mediated UVB-induced skin inflammation expression
Foxp3亚型和IgE介导的UVB诱导的皮肤炎症表达
  • 批准号:
    10728256
  • 财政年份:
    2023
  • 资助金额:
    $ 159.11万
  • 项目类别:
Regulation of Tfh function in autoimmunity by TSLP
TSLP 对自身免疫中 Tfh 功能的调节
  • 批准号:
    10441850
  • 财政年份:
    2022
  • 资助金额:
    $ 159.11万
  • 项目类别:
Regulation of Tfh function in autoimmunity by TSLP
TSLP 对自身免疫中 Tfh 功能的调节
  • 批准号:
    10571867
  • 财政年份:
    2022
  • 资助金额:
    $ 159.11万
  • 项目类别:
Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
Foxp3DEx2 同工型表达导致 Treg 功能障碍和 SLE
  • 批准号:
    10363690
  • 财政年份:
    2021
  • 资助金额:
    $ 159.11万
  • 项目类别:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
病毒引发的哮喘中 ECM 和白细胞粘附的上皮调节
  • 批准号:
    10160630
  • 财政年份:
    2020
  • 资助金额:
    $ 159.11万
  • 项目类别:
Epithelial control of responses to allergen challenge and viral exacerbation
上皮细胞对过敏原挑战和病毒恶化反应的控制
  • 批准号:
    10168800
  • 财政年份:
    2020
  • 资助金额:
    $ 159.11万
  • 项目类别:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
病毒引发的哮喘中 ECM 和白细胞粘附的上皮调节
  • 批准号:
    10202414
  • 财政年份:
    2020
  • 资助金额:
    $ 159.11万
  • 项目类别:
Generating tolerance to antibody-based drugs
产生对抗体药物的耐受性
  • 批准号:
    9258339
  • 财政年份:
    2017
  • 资助金额:
    $ 159.11万
  • 项目类别:
Epithelial control of responses to allergen challenge and viral exacerbation
上皮细胞对过敏原挑战和病毒恶化反应的控制
  • 批准号:
    9157669
  • 财政年份:
    2016
  • 资助金额:
    $ 159.11万
  • 项目类别:
IL-33 and food allergy
IL-33 和食物过敏
  • 批准号:
    9509328
  • 财政年份:
    2016
  • 资助金额:
    $ 159.11万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 159.11万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 159.11万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 159.11万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 159.11万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 159.11万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 159.11万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 159.11万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 159.11万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 159.11万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 159.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了